TEM-10.53%12.0%
CAI-9.80%11.0%
GH+203.57%9.0%
NTRA+104.38%9.0%
WGS-21.43%8.0%
SOPH+165.20%7.0%
GRAL+96.94%6.0%
VCYT+17.51%6.0%
MYGN-50.91%5.0%
NEO+131.15%5.0%
PSNL+176.46%5.0%
CDNA+259.31%4.0%
ADPT+106.54%3.0%
CSTL+43.41%3.0%
300676.SHE-17.53%2.0%
BNR+75.09%2.0%
FLGT-13.29%2.0%
000710.SHE-30.30%1.0%
As of Sep 18, 2026, 9:54 PM ET
Genomics '25: Clinical Genomics & Genomics Testing Constituents
Tempus AI, Inc.TEM | 12.0% | -3.14% | 21.18% | 57.83% | 25.11% | 31.93% | 46.30% | 56.15% | -10.53% | 55.40% | 93.39% | $13.64B |
Caris Life Sciences, Inc.CAI | 11.0% | -3.04% | 21.49% | 43.80% | 21.69% | 11.77% | 49.73% | 7.70% | -9.80% | 7.07% | 7.07% | $8.47B |
Guardant Health, Inc.GH | 9.0% | -2.03% | 10.88% | 11.48% | 8.57% | 74.76% | 90.10% | 310.44% | 203.57% | 606.50% | 35.84% | $24.07B |
Natera, Inc.NTRA | 9.0% | 0.84% | 13.41% | 17.94% | 14.60% | 60.46% | 76.70% | 156.70% | 104.38% | 190.56% | 192.33% | $52.90B |
GeneDx Holdings Corp.WGS | 8.0% | -3.67% | 19.61% | 34.54% | 21.10% | -21.03% | 28.85% | 21.01% | -21.43% | 148.71% | -67.37% | $3.02B |
SOPHiA GENETICS S.A.SOPH | 7.0% | -3.99% | 1.20% | 11.02% | 0.42% | 81.16% | 88.00% | 157.14% | 165.20% | 93.62% | -54.09% | $687.1M |
GRAIL Inc.GRAL | 6.0% | 1.03% | -1.43% | 9.99% | -2.28% | -8.90% | 46.48% | 198.28% | 96.94% | 482.34% | 297.49% | $3.47B |
Veracyte, Inc.VCYT | 6.0% | -1.91% | -8.01% | -4.01% | -10.09% | -7.24% | 6.72% | 29.61% | 17.51% | 12.89% | -22.28% | $3.18B |
Myriad Genetics, Inc.MYGN | 5.0% | -6.04% | 18.55% | 31.36% | 18.55% | -38.70% | -18.22% | -57.16% | -50.91% | -86.25% | -88.46% | $367.4M |
NeoGenomics, Inc.NEO | 5.0% | 0.10% | 13.47% | 25.31% | 14.18% | 69.43% | 102.70% | 111.52% | 131.15% | 20.81% | -58.80% | $511.6M |
Personalis, Inc.PSNL | 5.0% | 1.05% | -3.07% | 15.67% | -5.69% | 102.14% | 77.59% | 351.97% | 176.46% | 176.56% | -26.72% | $1.75B |
CareDx, IncCDNA | 4.0% | -0.83% | 5.49% | 14.92% | 8.37% | 181.69% | 182.89% | 188.58% | 259.31% | 80.15% | -20.80% | $2.78B |
Adaptive Biotechnologies CorporationADPT | 3.0% | 0.21% | 16.84% | 15.80% | 16.84% | 75.12% | 77.53% | 258.19% | 106.54% | 498.54% | -28.03% | $4.58B |
Castle Biosciences, Inc.CSTL | 3.0% | -3.92% | 2.70% | 15.90% | 0.61% | -13.51% | 13.78% | 66.64% | 43.41% | 15.76% | -54.29% | $1.08B |
BGI Genomics Co., Ltd.300676.SHE | 2.0% | 6.41% | 6.51% | 2.06% | 2.76% | -8.74% | -16.45% | -19.26% | -17.53% | 20.32% | -57.32% | $2.48B |
Burning Rock Biotech LimitedBNR | 2.0% | 8.80% | 37.49% | 58.16% | 59.71% | -26.92% | -42.99% | 244.85% | 75.09% | 309.40% | -93.03% | $15.0M |
Fulgent Genetics, Inc.FLGT | 2.0% | -0.73% | -3.47% | 5.01% | -0.46% | -25.77% | 27.20% | 10.67% | -13.29% | -5.24% | -76.35% | $616.0M |
Berry Genomics Co.,Ltd000710.SHE | 1.0% | 5.97% | 1.75% | 2.00% | -0.89% | -16.42% | -25.54% | -28.94% | -30.30% | 33.65% | -62.86% | $477.3M |
| Theme return | — | -1.48% | 11.26% | 25.88% | 12.71% | 44.24% | 64.65% | 146.98% | 75.97% | 188.44% | 115.88% | — |
| Average | 5.6% | -0.27% | 9.70% | 20.49% | 10.73% | 28.96% | 45.08% | 114.67% | 68.10% | 147.82% | -4.68% | $6.89B |
| Median | 5.0% | -0.78% | 8.70% | 15.74% | 8.47% | 2.26% | 46.39% | 89.08% | 59.25% | 67.78% | -41.06% | $2.63B |
| Std Dev | 3.1% | 3.84% | 11.27% | 17.64% | 15.59% | 57.64% | 54.20% | 120.25% | 89.74% | 192.82% | 100.28% | $12.59B |
| Min | 1.0% | -6.04% | -8.01% | -4.01% | -10.09% | -38.70% | -42.99% | -57.16% | -50.91% | -86.25% | -93.03% | $15.0M |
| Max | 12.0% | 8.80% | 37.49% | 58.16% | 59.71% | 181.69% | 182.89% | 351.97% | 259.31% | 606.50% | 297.49% | $52.90B |
| % Positive Tickers | 44.44% | 77.78% | 94.44% | 72.22% | 50.00% | 77.78% | 83.33% | 61.11% | 88.89% | 27.78% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Genomics '25: Clinical Genomics & Genomics Testing tracks 18 publicly listed stocks in this theme. Sample tickers: TEM, CAI, GH, NTRA, WGS, SOPH, GRAL, VCYT, MYGN, NEO, PSNL, CDNA, and 6 more. Use the table below for the full list.